Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.4148
+0.0137 (3.42%)
At close: May 20, 2025, 4:00 PM
0.4100
-0.0048 (-1.16%)
Pre-market: May 21, 2025, 5:24 AM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $6.30 million as of May 21, 2025. Its market cap has decreased by -88.10% in one year.
Market Cap
6.30M
Enterprise Value
5.50M
1-Year Change
-88.10%
Ranking
Category
Stock Price
$0.41
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $6.30M, a decrease of -90.46%. That is a compound annual growth rate of -71.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2025 | 6.30M | -76.31% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.89B |
| Johnson & Johnson | 366.90B |
| AbbVie | 328.04B |
| Novo Nordisk | 293.82B |
| UnitedHealth Group | 286.56B |
| Abbott Laboratories | 235.83B |
| Novartis AG | 215.48B |
| AstraZeneca | 214.95B |